DoseRT | Real-Time Dose Visualization

Revolutionize Treatment with Real-Time Dose Visualization & Patient Position Monitoring

Dose Visualization With SGRT Can Help Improve Treatment Quality

Radiation therapy is critical in cancer treatment, but even the slightest errors can have serious consequences.

DoseRT is a breakthrough technology that combines Cherenkov imaging with AlignRT and Horizon cameras, providing real-time visualization of dose delivery and patient positioning to prevent errors and improve clinical outcomes.

Cherenkov imaging with DoseRT has been clinically validated across multiple treatment sites, including breast, head & neck, lung, and SRS¹.

Benefits of DoseRT:

Reducing Secondary Cancer Risk

Published data suggests that approximately 2.6%² of breast cancer patients had secondary contralateral cancer attributable to radiation.

Detecting Treatment Errors Early

Research indicates that approximately 10%¹ of patients have errors in their treatment that can be detected by Cherenkov imaging.

Hear from users on their clinical experience:

“This is going to become the standard of care in radiotherapy.”

Michael Tallhamer Chief of Medical Physics, AdventHealth Parker, USA

“It is mostly used for the real-time surveillance of radiation therapy in order to detect irradiation errors.”

Dr. Florian Stieler, Medical Physicist, University Medical Center Mannheim, University of Heidelberg, Germany

What our customers say

“Cherenkoscopy is a unique method for visualizing surface dose, resulting in real-time quality control. We propose that this system could detect radiation therapy errors in everyday clinical practice at a time when these errors can be corrected to result in improved safety and quality of radiation therapy.”

Lesley Jarvis, MD, PhD Radiation Oncology Dartmouth Hitchcock Medical Center

“Cherenkov imaging is detecting approximately 8% errors with our patients. We can do better for our patients”

Adi Robinson, PhD, DABR Senior Medical Physicist, AdventHealth Celebration

“This is a big innovation from a quality and safety perspective. We don’t know what we don’t know. 6-8% of errors is a lot of errors.”

Matt Spraker, MD, PhD Radiation Oncologist, AdventHealth Parker

‌1. Jarvis et al. (2021). Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery. International Journal of Radiation Oncology*Biology*Physics, 109(5), pp.1627–1637.

2. Burt et al. (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. The Breast, 35, pp.122–129.

‌DoseRT is a Trademark of Vision RT. BeamSite is a trademark of DoseOptics LLC.

Get in touch

Ready to take the next step?

Vision RT’s family of SGRT solutions guide radiation therapy for better patient care at every step: Sim, Planning, Treatment and Dose. Whether you’re looking for a quote, a product demo (virtual or in-person) or just more information, please get in touch.

DoseRT™